HAYDEN BRIAN J 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Mar 7, 2007
Insider Transaction Report
Form 4
HAYDEN BRIAN J
SVP, Chief Financial Officer
Transactions
- Award
Common Stock, $.01 par value per share
2007-03-05$12.51/sh+12,500$156,375→ 36,360 total - Sale
Common Stock, $.01 par value per share
2007-03-05$12.52/sh−4,450$55,714→ 31,910 total
Footnotes (3)
- [F1]The right to receive these shares is pursuant to a performance based restricted stock grant, a portion of which vested on March 5, 2007.
- [F2]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of performance based restricted stock granted on July 5, 2006.
- [F3]Represents the average sale price. The highest price at which shares were sold was $12.521 and the lowest price at which shares were sold was $12.511.